Zasocitinib for palmoplantar psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests an experimental pill called zasocitinib for people with moderate-to-severe psoriasis on the palms and soles. It aims to reduce symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had non-pustular palmoplantar psoriasis (psoriasis on palms and/or soles) for at least 6 months.
- Your psoriasis is moderate to severe in these areas, as assessed by a doctor.
- You are a candidate for light therapy or systemic treatment (pills or injections).
- You have not used certain biologic drugs or JAK/TYK2 inhibitors within specific timeframes before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a daily pill (zasocitinib) for children and teens with moderate to severe plaque psoriasis that hasn't been controlled by other treatments. It aims to see if the pill can safely improve skin symptoms over a long period.
This study tests an investigational medication (zasocitinib) taken by mouth to reduce joint pain, swelling, and skin symptoms in adults with psoriatic arthritis. It is for people whose symptoms have not improved enough with standard treatments.
This trial tests an oral medication called zasocitinib for adults with psoriatic arthritis who have not tried biologic medicines before. It aims to see if the drug can improve joint pain, swelling, and skin symptoms.
This study is for people with psoriatic arthritis who have already completed a year-long treatment with zasocitinib or a similar medicine in a previous study. It tests whether continuing to take zasocitinib remains safe and helpful over a longer time.
This trial tests an oral medication called zasocitinib to see if it can help repigment skin in adults with nonsegmental vitiligo. It may be an option for people whose vitiligo covers a moderate amount of their body and who have not had certain recent treatments.
This trial tests a drug called bimekizumab for people with palmoplantar pustulosis (PPP), a skin condition causing painful pustules on the palms and soles. The goal is to see if the drug can clear these pustules and improve symptoms.
Hear when a new Palmoplantar Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.